Skip to content
bd@cod-research.com
+91 79 6947 8900
+1(732) 749-7719
Request for Proposal
About Us
Our Services
Clinical Development
Global Clinical Operations
Project Management
Global Regulatory
Regulatory Services
Biometrics
Clinical Trial Data Management
Biostatistics
Global Pharmacovigilance
Medical Information Solutions
ICSR & Literature Support
Medical Safety (Aggregate, Signal, Risk Management)
PSMF & Global QPPV Solutions
Clinical Safety
Quality Assurance
Good Clinical Practice (GCP)
Good Pharmacovigilance Practice (GVP)
Our Expertise
Therapy Areas
Specialties
Insights & Resources
Blogs & Articles
Case Studies
Brochures & Flyers
Webinars & Podcasts
COD Newsroom
Newsletter
Events & Conferences
Press Releases
COD Photo gallery
Careers
Contact Us
For Business Enquiries
For Conference Meetings
Connect with Experts
About Us
Our Servcies
Clinical Development
Global Clinical Operations
Project Management
Global Regulatory Solutions
Regulatory Services
Biometrics
Clinical Trial Data Management
Biostatistics
Global Pharmacovigilance
Medical Information Solutions
ICSR & Literature Support
Medical Safety (Aggregate, Signal, Risk Management)
PSMF & Global QPPV Solutions
Clinical Safety
Quality Assurance
Good Clinical Practice (GCP)
Good Pharmacovigilance Practice (GVP)
Our Expertise
Therapy Areas
Specialties
Insights & Resources
Blogs & Articles
Case Studies
Brochures & Flyers
Webinars & Podcasts
COD Newsroom
Newsletter
Events & Conferences
Press Releases
COD Photo gallery
Careers
Contact Us
For Business Enquiries
For Conference Meetings
Connect with Experts
Insights & Resources
Home
|
Insights & Resources
Clinical Trials
Pharmacovigilance
Regulatory
Corporate Presentation
Quality Assurance
Flyer
Medical Affairs
Read More
Flyer
CT Quality Assurance
Read More
Flyer
Clinical Services
Read More
Flyer
Biometrics
Read More
Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial
Read More
Blog
Strategic Planning for Patient Recruitment
Read More
Article
Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment
Read More
EMA
FDA
MHRA
Herbal medicinal product: Vitis viniferae folium, Vitis vinifera L., C: ongoing call for scientific data
Source: EMA
Published on 2025-06-18
Human medicines European public assessment report (EPAR): Pergoveris, follitropin alfa,lutropin alfa, Date of authorisation: 25/06/2007, Revision: 17, Status: Authorised
Source: EMA
Published on 2025-06-18
Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 29/07/2018, Revision: 13, Status: Authorised
Source: EMA
Published on 2025-06-18
Human medicines European public assessment report (EPAR): Rezzayo, rezafungin, Date of authorisation: 22/12/2023, Revision: 1, Status: Authorised
Source: EMA
Published on 2025-06-18
Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised
Source: EMA
Published on 2025-06-18
Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 33, Status: Authorised
Source: EMA
Published on 2025-06-18
Read More
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
FDA approves pembrolizumab for adenocarcinoma
Source: FDA
Published on 2025-04-08
Approved Drug Products with Therapeutic Equivalence Evaluations (Orang
Source: FDA
Published on 2025-04-08
Read More
Field Safety Notices: 9 to 13 June 2025
Source: MHRA
Published on 2025-06-17
Field Safety Notices: 9 to 13 May 2025
Source: MHRA
Published on 2025-06-17
MHRA Safety Roundup: May 2025
Source: MHRA
Published on 2025-06-13
Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection, Maxearn Limited, EL(25)A/27
Source: MHRA
Published on 2025-06-12
Class 4 Medicines Defect Notification: Dulcolax Adult 5 mg Gastro-resistant Tablets, Opella Healthcare UK, EL(25)A/26
Source: MHRA
Published on 2025-06-10
Field Safety Notices: 2 to 6 June 2025
Source: MHRA
Published on 2025-06-10
Read More